Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China flag China · Delayed Price · Currency is CNY
9.12
-0.33 (-3.49%)
Jun 19, 2025, 2:45 PM CST

SHE:301060 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Market Capitalization
3,6353,6345,3237,85413,910-
Upgrade
Market Cap Growth
-19.16%-31.73%-32.23%-43.54%--
Upgrade
Enterprise Value
3,2593,4465,2707,89013,408-
Upgrade
Last Close Price
9.128.9213.0118.8533.13-
Upgrade
PE Ratio
---12.7268.24-
Upgrade
PS Ratio
2.192.093.181.877.82-
Upgrade
PB Ratio
2.012.002.693.468.48-
Upgrade
P/TBV Ratio
2.242.243.063.869.15-
Upgrade
P/FCF Ratio
19.5526.0135.94-132.95-
Upgrade
P/OCF Ratio
14.1616.809.7393.3262.23-
Upgrade
EV/Sales Ratio
1.971.983.151.887.54-
Upgrade
EV/EBITDA Ratio
---6.9639.56-
Upgrade
EV/EBIT Ratio
---7.3745.58-
Upgrade
EV/FCF Ratio
17.5324.6735.58-128.15-
Upgrade
Debt / Equity Ratio
0.140.150.210.110.04-
Upgrade
Debt / EBITDA Ratio
24.8625.13-0.210.19-
Upgrade
Debt / FCF Ratio
1.411.962.75-0.63-
Upgrade
Asset Turnover
0.600.620.501.440.990.86
Upgrade
Inventory Turnover
3.844.183.508.957.725.26
Upgrade
Quick Ratio
2.522.682.312.073.884.96
Upgrade
Current Ratio
3.193.252.832.404.285.75
Upgrade
Return on Equity (ROE)
-5.63%-5.19%-7.61%37.78%18.12%10.93%
Upgrade
Return on Assets (ROA)
-1.48%-1.39%-2.89%22.88%10.28%6.89%
Upgrade
Return on Capital (ROIC)
-1.85%-1.74%-3.96%31.70%12.45%8.04%
Upgrade
Return on Capital Employed (ROCE)
---45.90%17.40%12.60%
Upgrade
Earnings Yield
-3.26%-3.01%-2.66%7.86%1.47%-
Upgrade
FCF Yield
5.11%3.84%2.78%-1.86%0.75%-
Upgrade
Dividend Yield
2.12%2.24%-1.59%0.91%-
Upgrade
Payout Ratio
---20.35%0.15%31.95%
Upgrade
Buyback Yield / Dilution
-0.47%-0.19%-1.00%-13.63%-0.02%0.02%
Upgrade
Total Shareholder Return
1.62%2.05%-1.00%-12.04%0.89%0.02%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.